About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Houston | 22,494 Studies Near You

Clinical TrialsHouston

Clinical Trials in Houston

Discover 22,494 clinical trials near Houston, Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 6921-6940 of 22,494 trials

CompletedA Safety Study Of Pregabalin In FibromyalgiaTo evaluate the safety of pregabalin in patients with fibromyalgia.NCT00282997·Little Rock, Arkansas and 71 others

Find Trials by Condition in Houston

Breast Cancerin Houston Lung Cancerin Houston Prostate Cancerin Houston Colorectal Cancerin Houston Melanomain Houston Leukemiain Houston Lymphomain Houston Pancreatic Cancerin Houston Ovarian Cancerin Houston Brain Cancerin Houston Diabetes

Data from ClinicalTrials.govTerms

UnknownTesetaxel as Second-line Therapy for Patients With Advanced Gastric CancerTesetaxel is an orally administered chemotherapy agent of the taxane class.NCT01095120·Chicago, Illinois and 3 others

Completed5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic DermatitisThe primary purpose of this study is to investigate the safety of pimecrolimus cream 1% in the long-term treatment (up to 5 years) of atopic dermatitis (eczema) in patients less…NCT00120523·Phoenix, Arizona and 30 others

CompletedPhase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD)Phase 2a, dose-ranging Study with PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD)NCT03248882·Bakersfield, California and 139 others

UnknownA First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid TumorsThis proposed Phase I clinical trial of SON-DP is an FIH, open-label, Phase Ia/Ib dose escalation and expansion study to evaluate the safety, tolerability, PK, and PD of SON-DP in…NCT05989724·Gilbert, Arizona and 4 others

CompletedSafety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell CarcinomaThe primary objective of this study is to assess the safety and efficacy of ABT-510 in subjects with advanced renal cell carcinoma.NCT00073125·Scottsdale, Arizona and 17 others

UnknownInjection Assistance Device Versus Manual Injections for Delivery of Dermal FillersThe purpose of this study is to characterize the safety and performance in normal therapeutic use of the Artiste System in comparison to standard manual administration of dermal…NCT01492140·New York, New York and 2 others

TerminatedDirect Lysis of Staph Aureus Resistant Pathogen Trial of ExebacaseThe purpose of this superiority study is to evaluate the efficacy and safety of exebacase in addition to standard of care antibiotics (SoCA) compared with SoCA alone for the…NCT04160468·Birmingham, Alabama and 54 others

RecruitingA Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Rosuvastatin on LDL-C in Patients With HypercholesterolaemiaThe purpose of this study is to evaluate the effect on low-density lipoprotein-cholesterol (LDL-C) and the safety and tolerability of a fixed dose combination (FDC) of…NCT07619118·Sun City West, Arizona and 44 others

RecruitingDose Escalation and Expansion of Ziftomenib in Combination With Quizartinib in Acute Myeloid LeukemiaThe goal of this all-oral combination is to deliver safe and effective therapy for the largest portion of AML subtypes (NPM1mt, KMT2Ar, NUP98r \~ 40-45%).NCT06769490·Houston, Texas

CompletedA Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, Both With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 DiabetesThis trial is conducted in Europe and the United States of America (USA).NCT02034513·Birmingham, Alabama and 98 others

CompletedRECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)The purpose of this study is to assess the recharge feature of the Activa RC System in patients who are receiving Deep Brain Stimulation (DBS) for Parkinson's Disease (PD)…NCT00998660·Washington D.C., District of Columbia and 10 others

CompletedPegasys and Copegus for Asian Patients With Treatment-naive Hepatitis C Genotypes 6, 7, 8, 9The purpose of this research study is to test the safety, tolerability, and effectiveness of the drugs Pegasys and Copegus when used for hepatitis C genotypes 6, 7, 8, and 9.NCT00575224·San Diego, California and 4 others

CompletedTarceva With Whole Brain Radiation Therapy - Brain Mets From Non-Small Cell Lung CancerThe goal of this clinical research study is to learn whether Tarceva (erlotinib hydrochloride), when given in addition to whole brain radiation therapy, is better to treat brain…NCT00871923·Tucson, Arizona and 1 other

AvailableIntermediate-size Patient Population Expanded Access ProtocolThe purpose of this Expanded Access Program is to provide tazbentetol to ALS patients who are not eligible to enroll in an ALS clinical trial.NCT07088159·Birmingham, Alabama and 15 others

CompletedACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic MalignanciesThis study is evaluating the safety, pharmacodynamics (PD), and efficacy of acalabrutinib and pembrolizumab in hematologic malignancies.NCT02362035·Tucson, Arizona and 18 others

CompletedFlublok or Fluzone With Advax-CpG55.2 or AF03This is a Phase I, randomized, double blinded, clinical trial in up to 240 males and non-pregnant females, 18-45 years of age, inclusive, who are in good health and meet all…NCT03945825·Atlanta, Georgia and 7 others

RecruitingA Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular DegenerationThe aim of this trial is to demonstrate similarity in efficacy between ABP 938 8 mg and aflibercept (US) 8 mg by evaluating the change in best corrected visual acuity (BCVA) in…NCT07614776·Fullerton, California and 80 others

CompletedPrevention of Recurrence of DiverticulitisThe purpose of this study is to determine whether SPD476 is effective in reducing recurrence of diverticulitis.NCT00545740·Litchfield Park, Arizona and 120 others

RecruitingEfficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma PatientsThe trial aims to evaluate the efficacy of Daromun neoadjuvant treatment followed by surgery and adjuvant therapy to improve in a statistically significant manner the…NCT03567889·Phoenix, Arizona and 36 others

PreviousPage 347 of 1125Next

in Houston

Heart Diseasein Houston